Information displayed below is a subset of the entire knowledge base and may be incorrect, or incomplete intensionally or inadvertently. If you detect a serious error or want access to the complete knowledge base, please contact us.
Endomyocardial fibrosis (EMF) is a rare, progressive, and potentially fatal heart disease that affects the inner lining of the heart (endocardium). It is characterized by the formation of fibrous tissue in the endocardium, which can lead to thickening of the heart walls and impaired heart function. Symptoms of EMF include shortness of breath, chest pain, fatigue, and irregular heart rhythms. Treatment typically involves medications to reduce inflammation and improve heart function, as well as lifestyle modifications such as quitting smoking and exercising regularly. In some cases, surgery may be necessary to remove the fibrous tissue.
All of the following must be considered when interpreting
clinical findings and are too extensive to be covered on
this site: